Xiaolong Cao

机构：Zhujiang Hospital, Southern Medical University · ORCID：0000-0001-8124-7491

发表论文 148 篇 · 总被引 3468 次 · h-index 32

代表论文

• Identifying CDC7 as a synergistic target of chemotherapy in resistant small-cell lung cancer via CRISPR/Cas9 screening (2023 · Cell Death Discovery · 被引 28)
• Rare X-linked variants carry predominantly male risk in autism, Tourette syndrome, and ADHD (2023 · Nature Communications · 被引 26)
• Molecularly Ordered Epoxy/Organic Acceptor Composites for Superior Thermal Transport and Electrical Insulation Performance (2025 · Advanced Functional Materials · 被引 21)
• Endogenous relapse and exogenous reinfection in recurrent pulmonary tuberculosis: A retrospective study revealed by whole genome sequencing (2023 · Frontiers in Microbiology · 被引 20)
• Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAF V600E ‐associated thyroid carcinoma (2024 · Clinical and Translational Medicine · 被引 14)
• Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China (2023 · Microbiology Spectrum · 被引 11)